U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802133) titled 'Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)' on Jan. 27.

Brief Summary: Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.

Study Start Date: Jan. 13

Study Type: OBSERVATIONAL

Condition: Repair of Dura Mater

Intervention: OTHER: Post Market Study

Prospective case series without a concurrent comparator group.

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Collagen Matrix

Disclaimer: Curated by HT Syndication....